Skip to main content

Table 1 Twenty-two subjects with a confirmed clinical/molecular diagnosis of ADNP syndrome

From: Gene domain-specific DNA methylation episignatures highlight distinct molecular entities of ADNP syndrome

ID

Age at blood draw

Sex

ADNP variant

Variant effect

Subtype

Dataset

ADNP_03a

11

M

c.103dupA (p.Ile35Asnfs*5)

Frame-shift

ADNP-1

Training

ADNP_17

12

F

c.190dupA (p.Thr64Asnfs*35)

Frame-shift

ADNP-1

Training

ADNP_16

4

M

c.539_542delTTAG (p.Val180Glyfs*17)

Frame-shift

ADNP-1

Testing

ADNP_25

5

M

c.819delC (p.Lys274Asnfs*31)

Frame-shift

ADNP-1

Training

ADNP_29

3

M

c.859_862dup (p.Gly288Aspfs*27)

Frame-shift

ADNP-1

Training

ADNP_23

10

M

c.1046_1047delTG (p.Leu349Argfs*49)

Frame-shift

ADNP-1

Testing

ADNP_08

2

M

c.1102C>T (p.Gln368*)

Nonsense

ADNP-1

Training

ADNP_05a

2

M

c.1106_1108delTACinsCTGT (p.Leu369Serfs*30)

Frame-shift

ADNP-1

Training

ADNP_12

4

F

c.1222_1223delAA (p.Lys408Valfs*31)

Frame-shift

ADNP-1

Training

ADNP_20

9

F

c.1287dupT (p.Ala430Cysfs*10)

Frame-shift

ADNP-1

Training

ADNP_15

12

F

c.2156_2157insA (p.Tyr719*)

Nonsense

ADNP-2

Training

ADNP_07

5

F

c.2157C>A (p.Tyr719*)

Nonsense

ADNP-2

Testing

ADNP_10

5

F

c.2157C>A (p.Tyr719*)

Nonsense

ADNP-2

Training

ADNP_14

5

M

c.2157C>A (p.Tyr719*)

Nonsense

ADNP-2

Training

ADNP_04

12

F

c.2157C>G (p.Tyr719*)

Nonsense

ADNP-2

Training

ADNP_11

4

F

c.2157C>G (p.Tyr719*)

Nonsense

ADNP-2

Testing

ADNP_21

4

M

c.2188C>T (p.Arg730*)

Nonsense

ADNP-2

Testing

ADNP_13

3

M

c.2268dup (p.Lys757Glnfs*4)

Frame-shift

ADNP-2

Training

ADNP_24

10

M

c.2287delT (p.Ser763Profs*9)

Frame-shift

ADNP-2

Training

ADNP_22

3

M

c.2287dupT (p.Ser763Phefs*3)

Frame-shift

ADNP-2

Training

ADNP_02a

8

M

c.2340T>G (p.Tyr780*)

Nonsense

ADNP-2

Training

ADNP_09

12

M

c.2419_2423delAAAAG (p.Lys807Glufs*6)

Frame-shift

ADNP-1

Testing

  1. aThe DNA methylation profiles of these three subjects were examined from blood samples collected years apart to evaluate the changes in the ADNP episignature over time (Additional file 1: Figure S1). Individuals are listed in ascending order according to the cDNA nomenclature. Mean ± standard deviation of all patients’ age 6.8 ± 3.8 (36% females), matched controls 7.9 ± 5.7 (37% females); epi-ADNP-1 subtype 7.2 ± 4.2 (25% females), matched controls 7.3 ± 4.2 (28% females); epi-ADNP-2 subtype age 6.3 ± 3.6 (32% females), matched controls 5.6 ± 3.6 (35% females); ADNP transcript NM_015339.2; Photographs of some of these subjects are provided in Additional file 1: Figure S1